A generic equivalent to Bristol-Myers Squibb’s entecavir (Baraclude) hepatitis B treatment has been approved by the FDA.
Aurobindo Pharma’s generic entecavir will soon be available in 0.5 mg and 1 mg oral tablet strengths.
Entecavir is a nucleoside analogue indicated to treat chronic hepatitis B infection in adults with evidence of active viral replication, though it may also be used in patients who have shown either persistent elevations in serum aminotransferases or histologically active disease. Entecavir does not cure chronic hepatitis B infection or prevent its spread
Read more....Labels: entecavir, generic Baraclude, generic entecavir, hbv treatment, treatment, treatment costs